Carbamic Acid

Carbamic Acid

SCHEMBL28177752

CONCc1ccccc1.NC(=O)O

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
ALDH1A1 P00352 1/20 0.46
TP53 P04637 1/20 0.46
GLA P06280 1/20 0.46
HPGD P15428 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
TSHR P16473 1/20 0.46
CYP2C19 P33261 1/20 0.46
NPC1 O15118 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
KMT2A Q03164 2/20 0.44
F2 P00734 1/20 0.44
PRSS1 P07477 1/20 0.44
PRSS2 P07478 1/20 0.44
PRSS3 P35030 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8252 0.88 CYP3A4 (0.52) MAPTCA1CA2ALDH1A1HPGD
Hydrochloric Acid SCHEMBL27904367 0.86 MAPT (0.56) MAPTCA1CA2ALDH1A1HPGD
Bromide SCHEMBL28406943 0.86 CYP3A4 (0.50) MAPTCA1CA2ALDH1A1HPGD
Naphthalene SCHEMBL9463547 0.82 CYP3A4 (0.46) MAPTCA1CA2KMT2AIDO1
SCHEMBL28377529 0.80 CYP3A4 (0.45) MAPTCA1CA2ALDH1A1HPGD
SCHEMBL2542923 0.78 CYP1A2 (0.47) MAPTL3MBTL1CA1CA2HPGD
Benzaldehyde SCHEMBL8037478 0.78 ALDH1A1 (0.50) MAPTCA1CA2ALDH1A1KMT2A
Trifluoromethanesulfonic Acid SCHEMBL3921319 0.78 HTT (0.43) MAPTCA1CA2ALDH1A1SMN1; SMN2
Carbamic Acid SCHEMBL15635796 0.77 HDAC8 (0.60) MAPTCA1CA2CYP1A2CYP2D6
Pyrimidine SCHEMBL28155909 0.77 CYP3A4 (0.42) MAPTALDH1A1HPGDCYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109966240-A The subcutaneously composition and method of fatty local delivery prostaglandin 托普凯恩制药公司 2019-07-05 CN disclosed
CN-109265400-A Arginine methyltransferase inhibitor and application thereof EPIZYME股份有限公司 2019-01-25 CN disclosed
CN-104718202-B The method for being used to prepare (S) -3- (4- ((4- (morpholinyl methyl) benzyl) oxygroup) -1- oxoisoindolines -2- base) piperidine-2,6-diones and its pharmaceutically acceptable form 细胞基因公司 2018-11-20 CN disclosed
CN-105209015-B Compositions and methods for local delivery of prostaglandins to subcutaneous fat 托普凯恩制药公司 2018-11-20 CN disclosed
CN-105339351-B Arginine methyltransferase inhibitors and uses thereof EPIZYME股份有限公司 2018-11-06 CN disclosed
CN-105228997-B Carm1 inhibitors and uses thereof EPIZYME股份有限公司 2018-03-27 CN disclosed
CN-105452226-B Tetrahydro-and dihydro-isoquinoline PRMT5 inhibitors and uses thereof EPIZYME股份有限公司 2017-09-12 CN disclosed